Sign in

CIK 0001159036

  • Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880488686
Phone
+1 858-794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
  1. 4 Open-market sale PRESIDENT AND CEO sold 30,000 shares at an average $51.01 ($1,530,150)
  2. 4 Grant or award Director acquired 1,188 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale PRESIDENT AND CEO sold 30,000 shares at an average $51.30 ($1,539,149)
  5. 4 Open-market sale SVP, CHIEF TECHNICAL OFFICER sold 10,000 shares at an average $50.46 ($504,590)
  6. 4 Shares withheld for taxes SVP, GENERAL COUNSEL gave up 2,804 shares (to pay taxes)
  7. 4 Open-market sale PRESIDENT AND CEO sold 30,000 shares at an average $58.11 ($1,743,302)
  8. 4 Open-market sale SVP, CHIEF TECHNICAL OFFICER sold 10,000 shares at an average $58.67 ($586,675)
  9. 4 Open-market sale Director sold 30,000 shares at an average $56.89 ($1,706,550)
  10. 4 Gift Director gave 9,250 shares (gift)
  11. 4 Gift Director gave 5,998 shares (gift)
  12. 4 Open-market sale PRESIDENT AND CEO sold 30,000 shares at an average $53.39 ($1,601,626)
  13. 4 Open-market sale SVP, CHIEF FINANCIAL OFFICER sold 5,000 shares at an average $53.81 ($269,053)
  14. 4 Open-market sale SVP, CHIEF TECHNICAL OFFICER sold 10,000 shares at an average $54.13 ($541,263)
  15. 4 Grant or award Director acquired 6,206 shares (grant or award)
  16. 4 Grant or award Director acquired 6,206 shares (grant or award)
  17. 4 Grant or award Director acquired 6,206 shares (grant or award)
  18. 4 Grant or award Director acquired 6,206 shares (grant or award)
  19. 4 Grant or award Director acquired 6,206 shares (grant or award)
  20. 4 Grant or award Director acquired 6,206 shares (grant or award)

Page 10 of 39 · 775 filings